title: Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine.
abstract: The target of neutralizing antibodies that protect against influenza virus infection is the viral protein HA. Genetic and antigenic variation in HA has been used to classify influenza viruses into subtypes (H1-H16). The neutralizing antibody response to influenza virus is thought to be specific for a few antigenically related isolates within a given subtype. However, while heterosubtypic antibodies capable of neutralizing multiple influenza virus subtypes have been recently isolated from phage display libraries, it is not known whether such antibodies are produced in the course of an immune response to influenza virus infection or vaccine. Here we report that, following vaccination with seasonal influenza vaccine containing H1 and H3 influenza virus subtypes, some individuals produce antibodies that cross-react with H5 HA. By immortalizing IgG-expressing B cells from 4 individuals, we isolated 20 heterosubtypic mAbs that bound and neutralized viruses belonging to several HA subtypes (H1, H2, H5, H6, and H9), including the pandemic A/California/07/09 H1N1 isolate. The mAbs used different VH genes and carried a high frequency of somatic mutations. With the exception of a mAb that bound to the HA globular head, all heterosubtypic mAbs bound to acid-sensitive epitopes in the HA stem region. Four mAbs were evaluated in vivo and protected mice from challenge with influenza viruses representative of different subtypes. These findings reveal that seasonal influenza vaccination can induce polyclonal heterosubtypic neutralizing antibodies that cross-react with the swine-origin pandemic H1N1 influenza virus and with the highly pathogenic H5N1 virus.
authors.affiliation: Institute for Research in Biomedicine, Bellinzona, Switzerland.
authors.forename: Davide
authors.initials: D
authors.lastname: Corti
authors.forename: Amorsolo L
authors.initials: AL
authors.lastname: Suguitan
authors.forename: Debora
authors.initials: D
authors.lastname: Pinna
authors.forename: Chiara
authors.initials: C
authors.lastname: Silacci
authors.forename: Blanca M
authors.initials: BM
authors.lastname: Fernandez-Rodriguez
authors.forename: Fabrizia
authors.initials: F
authors.lastname: Vanzetta
authors.forename: Celia
authors.initials: C
authors.lastname: Santos
authors.forename: Catherine J
authors.initials: CJ
authors.lastname: Luke
authors.forename: Fernando J
authors.initials: FJ
authors.lastname: Torres-Velez
authors.forename: Nigel J
authors.initials: NJ
authors.lastname: Temperton
authors.forename: Robin A
authors.initials: RA
authors.lastname: Weiss
authors.forename: Federica
authors.initials: F
authors.lastname: Sallusto
authors.forename: Kanta
authors.initials: K
authors.lastname: Subbarao
authors.forename: Antonio
authors.initials: A
authors.lastname: Lanzavecchia
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry; D057134:Antibodies, Neutralizing / Q000737:chemistry*; D001665:Binding Sites; D004285:Dogs; D018604:Epitope Mapping / Q000379:methods; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D007252:Influenza Vaccines / Q000276:immunology*; D007251:Influenza, Human / Q000517:prevention & control*; D007963:Leukocytes, Mononuclear / Q000166:cytology; D051379:Mice; D008807:Mice, Inbred BALB C; D009154:Mutation; D009975:Orthomyxoviridae / Q000378:metabolism; D011485:Protein Binding
chemical_list: D000911:Antibodies, Monoclonal; D057134:Antibodies, Neutralizing; D007074:Immunoglobulin G; D007252:Influenza Vaccines
references.citation: PLoS One. 2008;3(12):e3942
references.pmid: 19079604
references.citation: Science. 2009 Apr 10;324(5924):246-51
references.pmid: 19251591
references.citation: Nature. 1981 Jan 29;289(5796):373-8
references.pmid: 6162101
references.citation: Emerg Infect Dis. 2008 Jan;14(1):121-8
references.pmid: 18258091
references.citation: Virology. 2004 Aug 1;325(2):287-96
references.pmid: 15246268
references.citation: Nat Med. 2004 Aug;10(8):871-5
references.pmid: 15247913
references.citation: PLoS Med. 2009 Apr 21;6(4):e1000049
references.pmid: 19381279
references.citation: Microbiol Rev. 1992 Mar;56(1):152-79
references.pmid: 1579108
references.citation: Annu Rev Biochem. 2000;69:531-69
references.pmid: 10966468
references.citation: J Exp Med. 1966 Sep 1;124(3):331-45
references.pmid: 5922742
references.citation: Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1871-6
references.pmid: 11779386
references.citation: Nat Med. 2009 Nov;15(11):1251-2
references.pmid: 19893556
references.citation: Influenza Other Respir Viruses. 2007 May;1(3):105-12
references.pmid: 19453415
references.citation: Virology. 2006 Sep 1;352(2):418-26
references.pmid: 16777168
references.citation: J Clin Invest. 1996 May 1;97(9):2074-80
references.pmid: 8621797
references.citation: Nature. 1981 Jan 29;289(5796):366-73
references.pmid: 7464906
references.citation: J Virol. 2005 Mar;79(5):2814-22
references.pmid: 15709000
references.citation: J Immunol. 1979 Aug;123(2):825-32
references.pmid: 88484
references.citation: Immunology. 2006 Sep;119(1):1-7
references.pmid: 16925526
references.citation: Science. 2004 Jul 16;305(5682):371-6
references.pmid: 15218094
references.citation: Acta Virol. 1999 Aug;43(4):237-44
references.pmid: 10749369
references.citation: J Virol. 2002 Feb;76(3):1369-78
references.pmid: 11773411
references.citation: Nat Struct Mol Biol. 2009 Mar;16(3):265-73
references.pmid: 19234466
references.citation: PLoS Pathog. 2009 Jun;5(6):e1000482
references.pmid: 19557166
references.citation: J Virol. 1986 Jan;57(1):124-8
references.pmid: 3941436
references.citation: Nature. 2007 Sep 6;449(7158):101-4
references.pmid: 17805298
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 22;105(16):5986-91
references.pmid: 18413603
references.citation: PLoS Med. 2006 Sep;3(9):e360
references.pmid: 16968127
references.citation: J Virol. 1993 May;67(5):2552-8
references.pmid: 7682624
references.citation: Annu Rev Immunol. 1990;8:737-71
references.pmid: 2188678
references.citation: J Virol. 1994 Jan;68(1):517-20
references.pmid: 8254764
references.citation: Vaccine. 2009 Oct 9;27(43):5998-6003
references.pmid: 19665606
references.citation: Eur J Immunol. 2009 May;39(5):1260-70
references.pmid: 19404981
references.citation: J Clin Microbiol. 1999 Apr;37(4):937-43
references.pmid: 10074505
references.citation: Cell. 1982 Dec;31(2 Pt 1):417-27
references.pmid: 6186384
references.citation: PLoS Pathog. 2009 Mar;5(3):e1000350
references.pmid: 19300497